{"id":"F2008B00067","name":"National Health Act 1953 - Declaration under subsection 85(2AA) (No. PB 2 of 1996)","slug":"national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-2-of-1996","collection":"legislative_instrument","jurisdiction":"commonwealth","status":"repealed","isInForce":false,"actNumber":null,"makingDate":null,"administeringDepartment":null,"currentVersion":{"id":72276,"registerId":"commonwealth-F2008B00067-current","compilationNumber":null,"startDate":"2026-04-02","status":"Repealed","reasons":null,"registeredAt":null},"sections":[{"sectionNumber":"1","sectionType":"section","heading":"National Health Act 1953 - Declaration under subsection 85(2AA) (No. PB 2 of 1996)","content":"COMMONWEALTH OF AUSTRALIA\n\nNational Health Act 1953\n\nPHARMACEUTICAL BENEFITS\n\nDECLARATION UNDER SUBSECTION 85 (2AA)\n\nNo. PB 2 of 1996\n\nI, DAVID TREVOR GRAHAM, Assistant Secretary, Pharmaceutical Benefits Branch, Department of Human Services and Health and Delegate of the Minister for Human Services and Health, having in accordance with subsection 85 (2AB) of the National Health Act 1953 obtained the advice of the Pharmaceutical Benefits Advisory Committee, pursuant to subsection 85 (2AA) of the National Health Act 1953, hereby make the following Declaration:\n\n1. This Declaration shall come into operation on 1 February 1996.\n\n2. The drugs and medicinal preparations specified in the Schedule to this Declaration shall cease to be drugs and medicinal preparations to which Part VII of the National Health Act 1953 applies.\n\nTHE SCHEDULE\n\nEtretinate\n\nNeostigmine Bromide\n\nOxymetholone\n\nThioridazine\n\n“XP Albumaid”\n\nDated this eleventh day of January 1996.\n\nD. GRAHAM\n\nAssistant Secretary\n\nPharmaceutical Benefits Branch\n\nDepartment of Human Services and Health\n\nDelegate of the Minister for Human Services and Health","sortOrder":0}],"analysis":{"kimi_summary":{"_metrics":{"model":"kimi-k2.5","source":"moonshot-batch","completionTokens":1486},"content_quality":"ok","complexity_score":1,"scope_assessment":{"changed":false,"description":"The declaration remains strictly limited to its original purpose of removing specific pharmaceutical products from PBS subsidy. No expansion of scope or additional provisions have been added."},"complexity_factors":["Single page document with minimal text (under 200 words)","No defined terms or interpretation section requiring legal analysis","Simple list structure with no conditional logic, exceptions, or triggers","Only one operative provision (the delisting) with a clear effective date","No cross-references to other legislative provisions beyond the enabling power"],"plain_english_summary":"**What this does:** This declaration removes five specific medications from Australia's Pharmaceutical Benefits Scheme (PBS). The PBS is the government program that subsidizes prescription medicines to make them cheaper for patients.\n\n**Who it affects:** Anyone taking these specific drugs will now pay full commercial price instead of the government-subsidized price:\n* **Etretinate** – used for severe psoriasis and other skin conditions\n* **Neostigmine Bromide** – treats muscle weakness disorders such as myasthenia gravis\n* **Oxymetholone** – an anabolic steroid used for certain blood disorders\n* **Thioridazine** – an antipsychotic medication\n* **\"XP Albumaid\"** – a nutritional supplement product\n\n**When it takes effect:** 1 February 1996.\n\n**Why it matters:** Delisting means these medicines become significantly more expensive for patients because they lose government funding. This typically occurs when safer or more effective alternatives become available, the drug is rarely prescribed, or the cost to taxpayers outweighs the medical benefit."}},"importantCases":[],"_links":{"self":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-2-of-1996","history":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-2-of-1996/history","analysis":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-2-of-1996/analysis","conflicts":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-2-of-1996/conflicts","importantCases":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-2-of-1996/important-cases","documents":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-2-of-1996/documents"}}